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To my dearest ones 
(who knows, knows). 
 
 
  
 
 
 
 
 
 
“No man is an island entire of itself; every man is a piece of the continent, a part of the main; if a 
clod be washed away by the sea, Europe is the less, as well as if a promontory were, as well as 
any manner of thy friends or of thine own were; any man's death diminishes me, because I am 
involved in mankind. And therefore never send to know for whom the bell tolls; it tolls for thee.” 
 
John Donne 
 
 
 
 
 
 
 
…Serendipità è dunque - filosoficamente - lo scoprire una cosa non cercata e imprevista mentre 
se ne sta cercando un'altra. Ma il termine non indica solo fortuna: per cogliere l'indizio che 
porterà alla scoperta occorre essere aperti alla ricerca e attenti a riconoscere il valore di 
esperienze che non corrispondono alle originarie aspettative…. 
 
 
 
 
 
 
 
“With dreams to be a king, first one should be a man 
I call about and charge them all with a life that is a lie” 
Manowar, "Warriors of the world" 
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CHAPTER I – INTRODUCTION 
 
 
1.1 Protein deposition diseases: a brief overview 
 
1.1.1 The protein misfolding/misfunction problem 
One of the most challenging issues in modern molecular medicine is probably 
to gain a full understanding of the equilibria between fully folded and 
functional structures of proteins and potentially dangerous states, including 
partially or fully unfolded states as well as native-like states, that may lead to 
formation of misfolded structures ultimately causing disease. Each protein 
attains a unique correct and functional fold, that is the so-called “native state”. 
The native state is usually reached shortly after translation, often with the co-
operation of other proteins with chaperone functions. It is widely accepted that 
the bare amino acidic sequence of a protein contains the essential information to 
acquire the definitive three-dimensional structure. It is also well known that the 
native state is, in most cases, the thermodynamically most stable of all the 
conformations that the polypeptide chain can theoretically adopt (1,2). On the 
other hand, it is obvious that the number of possible conformations is so huge 
that a search of the correct one, simply by making attempts, would take 
absolutely too much time. In past years, it has been clarified that the folding 
process does not involve a linear series of mandatory steps between specific 
partly folded states, but rather a stochastic search of the many conformations 
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accessible to a polypeptide chain in a range of possibilities known as “energy 
landscape” (Fig. 1.1) (3-5). Considering that native-like interactions are usually 
more stable than non-native ones, the folding process is very likely to be seen as 
a series of progressive “guided” attempts, rather than a random sampling of 
possibilities. 
 
 
Figure 1.1 Free-energy (F) surface of a 27-mer model protein as a function of the number of 
native contacts (Q0) and the total number of (native and non-native) contacts (C) obtained by 
sampling the accessible configuration space using Monte Carlo simulations. The yellow 
trajectory shows the average path traced by structures in 1000 independent trials that each 
began in a different random conformation. The other two trajectories (green and red) show a 
range of two standard deviations around the average and are thus expected to include ca. 95% 
of the trajectories. The structures illustrate the various stages of the reaction. From one of the 
1016 possible random starting conformations, a folding chain collapses rapidly to a disorderd 
globule It then makes a slow, non-directed search among the 1010 semi-compact conformations 
for one of the approximately 103 transition states that lead rapidly to the unique native state. 
(Figure and caption from(6)) 
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Both prokaryotic and eukaryotic cells have developed a very efficient 
cellular machinery , both at translational and post-translational level, that can 
monitor the protein folding process from the ribosome to the fully functional 
native state (7-10). If the correct folding process fails, the resulting polypeptide 
chain can be conformationally re-modeled by specific chaperones in an attempt 
to give it the correct conformation, or be just ubiquitinated and degraded back 
to amino acids. Sometimes the complex machine that control protein folding 
homeostasis is poorly functional or even impaired, due to unfavourable 
environmental conditions like pH, temperature (heat shock), oxidative stress, 
aging or it can be damaged by chemical interactions or gene mutations, or even 
uncorrect folding/assembly of the chaperones itself. In these cases the 
misfolded polypeptides/proteins are not eliminated and remain in the cell or in 
the extracellular space, where they can pack together and accumulate giving 
rise to protein assemblies (11,12). If there is a massive degradation of non-
functional forms of a protein, this can lead to a significant reduction of the 
physiological level of the native state and then to a lack of the associated 
metabolic function; a typical example is cystic fibrosis (13,14). In other cases, an 
uncorrect folding causes an improper binding and trafficking of the 
polypeptide, as in familial hypercholesterolemia (15) or early-onset emphysema 
(16). In a great number of cases the misfolded proteins can self-assemble into 
insoluble fibrillar structures that form deposits in the cytosol or, more 
commonly, in the extracellular space, giving rise to a variety of pathological 
conditions well known as “protein deposition diseases”. These pathological 
conditions include some of the most invalidant syndromes of our century, such 
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as Parkinson’s disease, type-II diabetes, spongiform encephalopaties and 
systemic amyloidosis. 
 
1.1.2 Protein deposition diseases arising from amyloid aggregation 
There is a large subset of conformational diseases that show, as a common 
feature, the presence of non-functional and highly ordered fibrillar aggregates 
with amyloid or amyloid-like structure. This term was given after the 
observation that these fibrils, at first sight, looked like starch crystals, but it is 
well known today that they possess a well-defined structure and morphology 
(see section 1.2). These structures usually originate from proteins that are 
normally soluble and functional, either as a fully folded state or as intrinsically 
disordered proteins (17). Although the term “amyloid” is generally used to 
refer to extracellular deposits, it is increasingly recognized that even 
intracellular proteinaceous inclusions share the same structural and 
morphological features (18,19). A basical overview of protein deposition 
diseases should consider three fundamental categories: neuropathic conditions, 
non-neuropathic localized amyloidoses, and non-neuropathic sistemic 
amyloidoses. In the first group of pathologies, aggregation occurs in the central 
nervous system; in the other types of amyloidoses, protein deposition occurs in 
a single type of tissue other than the brain, or in multiple tissues in the whole 
body, respectively (17). This wide range of pathologies includes both sporadic 
and hereditary forms, the latter arising from the presence of specific mutations, 
often geographically localized (e.g. British and Danish dementia, Finnish 
hereditary amyloidosis, etc…). In addition, there are also some forms of 
spongiform encephalopathies that have been demonstrated to be transmissible. 
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Other diseases arise from medical treatment, such as dialysis-related 
amyloidosis and injection-localized amyloidosis. Table 1.1 lists some of the 
most widely studied protein deposition diseases associated with amyloid or 
amyloid-like structure (17). 
 
Table 1.1 Human diseases associated with formation of extracellular amyloid 
deposits or intracellular inclusions with amyloid-like characteristics (17). 
Disease Aggregating protein or 
peptide 
Number of 
residues of 
protein or 
peptidea 
 Native Structure of 
protein or    peptideb 
 Neurodegenerative diseases  
Alzheimer’s diseasec Amyloid ! peptide 40 or 42f Natively unfolded 
Spongiform 
encephalopathiesc,e 
Prion protein or 
fragments thereof 
253 Natively unfolded 
(residues 1-120) and 
"-helical (121-230)  
Parkinson’s diseasec "-Synuclein 140 Natively unfolded 
Dementia with Lewy 
bodiesc 
"-Synuclein 140 Natively unfolded 
Frontotemporal dementia 
with Parkinsonismc 
Tau 352-441f Natively unfolded 
Amyotrophic lateral 
sclerosisc 
Superoxide dismutase 1 153 All-!, Ig like 
Huntington’s diseased Huntingtin with polyQ 
expansion 
3144g Largely natively 
unfolded 
Spinocerebellar ataxiasd Ataxins with polyQ 
expansion 
816g,h All-!, AXH domain 
(residues 562-694); the 
rest are unknown 
Spinocerebellar ataxia 17d TATA box-binding 
protein with polyQ 
expansion 
339g "+!, TBP like 
(residues 159-339); 
unknown (1-158) 
Spinal and bulbar muscular 
atrophyd 
Androgen receptor with 
polyQ expansion 
919g All-", nuclear 
receptor ligand-
binding domain (669-
919); the rest are 
unknown 
Hereditary dentatorubral-
pallidoluysian atrophyd 
Atrophin-1 with polyQ 
expansion 
1185g Unknown 
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Familial British dementiad ABri 23 Natively unfolded 
Familial Danish dementiad ADan 23 Natively unfolded 
Nonneuropathic systemic amyloidoses 
AL amyloidosisc Immunoglobulin light 
chains or fragments 
~ 90f All-!, IG like 
AA amyloidosisc Fragments of serum 
amyloid A protein 
76-104f All-", unknown fold 
Familial Mediterranean 
feverc 
Fragments of serum 
amyloid A protein 
76-104f All-", unknown fold 
Senile systemic amyloidosisc Wild-type transthyretin 127 All-!, prealbumin like 
Familial amyloidotic 
polyneuropathyd 
Mutants of transthyretin 127 All-!, prealbumin like 
Hemodialysis-related 
amyloidosisc 
!2-microglobulin 99 All-!, Ig like 
ApoAI amyloidosisd  N-terminal fragments of 
apolipoprotein AI 
80-93f Natively unfolded 
ApoAII amyloidosisd N-terminal fragment of 
apolipoprotein AII 
98i Unknown 
ApoAIV amyloidosisc N-terminal fragment of 
apolipoprotein AIV 
~ 70 Unknown 
Finnish hereditary 
amyloidosisd 
Fragments of gelsolin 
mutants 
71 Natively unfolded 
Lysozyme amyloidosisd Mutants of lysozyme 130 "+!, lysozyme fold 
Fibrinogen amyloidosisd Variants of fibrinogen "-
chain 
27-81f Unknown 
Icelandic hereditary cerebral 
amyloid angiopathyd 
Mutant of cystatin C 120 "+!, cystatin like 
Nonneuropathic localized diseases 
Type II diabetesc Amylin, also called islet 
amyloid polypeptide 
(IAPP) 
37 Natively unfolded 
Medullary carcinoma of the 
thyroidc 
Calcitonin 32 Natively unfolded 
Atrial amyloidosisc Atrial natriuretic factor 28 Natively unfolded 
Hereditary cerebral 
haemorrhage with 
amyloidosisd 
Mutants of amyloid ! 
peptide 
40 or 42f Natively unfolded 
Pituitary prolactinoma Prolactin 199 All-", 4-helical 
cytokines 
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Injection-localized 
amyloidosisc 
Insulin 21 + 30j All-", insulin like 
Aortic medial amyloidosisc Medin 50k Unknown 
Hereditary lattice corneal 
dystrophyd 
Mainly C-terminal 
fragments of kerato-
epithelin 
50-200f Unknown 
Corneal amylodosis 
associated with trichiasisc 
Lactoferrin 692 "+!, periplasmic-
binding protein like II 
Cataractc #-Crystallins Variable All-!, #-crystallin like 
Calcifying epithelial 
odontogenic tumorsc 
Unknown ~ 46 Unknown 
Pulmonary alveolar 
proteinosisd 
Lung surfactant protein 
C 
35 Unknown 
Inclusion-body myositisc Amyloid ! peptide 40 or 42f Natively unfolded 
Cutaneous lichen 
amyloidosisc 
Keratins Variable Unknown 
aData refer to the number of residues of the processed polypeptide chains that deposit into 
aggregates, not of the precursor proteins. 
bAccording to Structural Classification Of Proteins (SCOP), these are the structural class and 
fold of the native states of the processed peptides or proteins that deposit into aggregates 
prior to aggregation. 
cPredominantly sporadic, although in some cases hereditary forms associated with specific 
mutations are well documented. 
dPredominantly hereditary although in some cases sporadic forms are documented. 
e 5% of the cases are infectious (iatrogenic). 
fFragments of various lengths are generated and have been reported to be present in ex vivo 
fibrils. 
gLengths shown refer to the normal sequences with nonpathogenic traits of polyQ. 
hLength shown is for ataxin-1.  
iThe pathogenic mutation converts the stop codon into a Gly codon, extending the 77-residue 
protein by 21 additional residues. 
jHuman insulin consists of two chains (A and B with 21 and 30 residues, respectively) 
covalently linked by disulfide bridges. 
kMedin is the 245-294 fragment of human lactadherin. 
 
 This correlation between amyloid fibril formation and such a wide range 
of socially relevant and often incurable pathologies has lead to a great interest 
in unraveling the mechanisms of aggregation processes, both from a biomedical 
and a biophysical point of view. Evidence is now emerging that amyloid 
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aggregation is in fact one of the fundamental structural states of polypeptide 
chains that arises from very basic physical principles (4,20). In fact, it is now 
evident that amyloidogenic proteins do not share any obvious sequence or 
structural similarity in their native states, and they are also very different in 
secondary structure composition. Moreover, a large variety of proteins that are 
not associated with disease, even syntethic polymers, may are able to form 
supramolecular assemblies similar to amyloids, thus suggesting that these 
aggregation phenomena share common grounds (17,21). 
 
1.2 Amyloid fibril structure  
 
Amyloid fibrils are supramolecular structures whose main components are 
twisted rods called protofilaments, that are made of protein monomers stacked 
one on another. These protofilaments are are usually rich in !-sheet structure, 
and measure about 2-5 nm in diameter (22). In the fibril, the !-strands are 
usually perpendicular to the main axis (23). The protofilaments assemble as 
fibrils by generally twisting like an helix into rope-like structures, about 7-13 
nm wide (22,23). 
Classical and wide used techniques to image amyloid fibrils were microscopies 
such as Transmission Electron Microscopy (TEM) or Atomic Force Microscopy 
(AFM), and X-ray fiber di!raction (22-24).  
Amyloid fibrils possess three main hallmarks that are present 
independently of the precursor protein that form them: 
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(i) A well-defined fibrillar morphology observable with TEM or AFM (Fig. 1.2) 
(23,25-27);  
(ii) The presence of a cross-! structure observed by X-ray fibre diffraction (Fig. 
1.3) (25) 
(iii) A green birefringence observed under cross-polarized light after Congo 
Red (CR) staining (Fig. 1.4) (28). 
 
 
Figure 1.2 a) amyloid fibrils of the A!1-40 peptide by transmission electron microscopy 
 (26); b) amyloid fibrils of A!1-42 peptide by atomic force microscopy (27). 
 
 
              a                            b 
 
Figure 1.3 (left) X-ray fibre diffraction patterns of (a) a partially aligned sample of A!1-40 
amyloid ¢brils and (b) a magnetically aligned sample of A!1-40 amyloid fibrils. (right) the 
characteristic cross-L spacings from X-ray ¢bre di¡raction from amyloid ¢brils. A strong 4.8 Ä 
reflection on the meridian corresponds to the hydrogen bonding distance between L-strands 
(shown right), and a more diffuse 10-11 Ä reflection on the equator shows the intersheet 
distance of about 10.7 Ä. A spacing of 9.6 Ä would correspond to the repeat distance for an anti-
parallel arrangement of L-strands. Figure and captions from (25)  
 
 
 
Figure 1.4 C!2microglobulin fibrils stained with 120 !M Congo Red 
solution. When viewed under cross-polarized light, the sample 
exhibits apple-green birefringence typical for amyloid fibrils.  (28) 
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Figure 1.5 Three dimensional models of fibrillar amyloid aggregates.  
a) The protofilament of the A! peptide as viewed along the axis of the fibril. b) The fibril from 
the C-terminal domain of the fungal prion protein HET-s. c) Atomic structure of the 
microcrystals assembled from the GNNQQNY peptide, where each peptide forms one !-strand. 
d)The protofilament from amylin, with an un-structured N-terminal tail bearing a disulfide 
bridge. e)The fibril from the NM region of Sup35p.  
Figure and caption adapted from (17). 
 
For a long time the ultrastructure of amyloid fibrils has been poorly 
characterized because they are too large and insoluble to be used for solution 
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NMR experiments and do not crystallize properly for X-ray crystallography 
measurements. Recently these limitations have been partially overcomed 
follwing the application of solid-state NMR (SSNMR) spectroscopy (29-31) and 
the characterization of peptide fragments that model essential structural 
features of amyloid fibrils and can be studied by mean of X-ray 
microcrystallography (32,33). Examples of  well-characterized structural model 
obtained using different techniques are given in Figure 1.5 (17) . 
 
1.3 The utility of using model proteins to study the 
fundamentals of protein aggregation 
 
The principal aim of studying the mechanism of protein aggregation is to obtain 
a deeper knowledge on a great number of diseases of very high social and 
economical impact. Nevertheless, it is well known that a huge number of 
proteins, if not all, can give rise to amyloid aggregation (34). Several proteins 
that are not involved in disease were shown to form amyloid-like aggregates 
using particular organic cosolvents, a high temperature, high pressure, or pH 
extremes (35-38). More recently, a combination of agitation and high salt 
concentration has been used to form amyloid fibrils from one of such proteins 
(39). A few examples of such proteins are reported in Table 1.2 (21). 
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Table 1.2 Non-disease related amyloidogenic proteins and peptides 
 
 
Studies based on small, low-molcular weight proteins or even shorter 
polypeptides, including ex-novo designed ones, can help investigator to focus 
on one aspect at a time, i.e. the presence of particular conformations on the 
backbone, small variations of charge, the presence of small sequence repeats, 
etc. (40-44). In addition, the study of large numbers of systems, as opposed to 
the few systems associated with disease, allows statistics of the various 
determinants involved in the process to be obtained (45,46). Performing 
experiments on relatively small proteins and peptides is also of great help in 
translating experimental observations into computational models and 
algorithms, because the possibilities of evaluate correctly the importance of 
each parameter involved in the process increase as the system complexity 
decreases (47-50). 
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1.4 Mechanism of amyloid fibril formation  
 
1.4.1 General features on aggregation  
The obtainement of a complete a description of the aggregation process of a 
protein is not certainly a simple task. There can be a quite large number of 
different phases and intermolecular associations in the aggregation process, 
different kinds of oligomeric species and even different types of amyloid fibrils 
co-populated at the final stage. An important issue is also the determination of 
the thermodynamics and kinetics of all the discrete phases involved in the 
process in which conformational changes occur and the structures of all the 
monomeric and oligomeric species that form during aggregation.   
 The time course of amyloid fibril formation usually consists of an initial 
phase, called “lag” phase, during which no detectable formation of fibrils 
occurs (51). This phase is due to the time required for the first aggregation 
nuclei to constitute. During the lag phase a variety of oligomeric aggregates 
form, not just the nuclei for the formation of mature fibrils, but also dimers, 
small oligomers, protofibrils, etc. (26,27). After this phase, which can vary 
greatly in time, from a few minutes or hours to days or even weeks, a rapid 
exponential growth of fibrils occur (52-54) by association of monomers or other 
oligomers to the pre-formed nuclei (fig. 1.6). Aggregation of protein into 
amyloid fibrils is therefore thought to be consistent with a “nucleated growth” 
mechanism.  
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Figure 1.6 AFM images of the time course of fibril formation by A! 1-40 (at 45 µM, top row) and 
A! 1-42 (at 20 µM, bottom row). For both A! 1-40 and A! 1-42, the progression from small 
protofibrils to longer protofibrils to fibrils of two types is clear, as is the absence of protofibrils 
at the latest time points. The progression from protofibrils to fibrils occurs more rapidly for A! 
1-42, despite the fact that protein concentration is lower. Figure and caption adapted from (24). 
 
 In analogy with other nucleated growth systems (for example crystal 
growth), it is possible to “seed” the solution with ready made fibrils to increase 
the rate of fibril growth: this avoids the need for nucleation and consequently 
the lag phase results to be shortened, or even canceled (52,53). 
In same experimental conditions the lag phase can be influenced or deleted, 
probably creating a situation in which nucleation in no longer rate-limiting 
(55,56). Anyway, the absence of the lag phase does not ensure us on the absence 
of a nucleated growth: it can simply mean that the main fibril formation occurs 
on time-scale comparable to that of first nucleation process (17). 
 
1.4.2 Oligomers and protofibrils 
The oligomeric species that preceed the formation of amyloid fibrils have been 
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the subject of great scientific attention recently (57-61). They are considered 
very important for two reasons. First, they are the main intermediate species 
between monomers and amyloid fibrils, and their study and comprehension 
can shed light on aggregation pathways. Second, they are thought to be the real 
active forms responsible for the onset of many protein deposition diseases, the 
amyloid fibrils representing rather an inert dead-end product (62,63). Among 
the various prefibrillar species, the most commonly observed aggregates are 
those assemblies that are often termed protofibrils (24,26). These species show a 
significant structural regularity. For example, the aggregation process of the 
amyloid ! peptide involves the early appearance of a variety of nonfibrillar 
species, visible using AFM or TEM (24,26). The simplest “unit” seems to be a 
spherical aggregate, of about 20 monomers, that assembles into chains that can 
be straight, curved, or even circular (24,26,64). In all cases protofibrils have a 
diameter of ca. 2-5 nm. Protofibrils are able to bind to ThT and CR and possess 
an extensive !-sheet content, as indicated by far-UV circuar dichroism 
measurements (26,64-66). 
 Many other amyloid-forming proteins can form similar structures, 
including "-synuclein (67), poly-glutamine repeats (64), !2-microglobulin (68), 
the acylphosphatase from Sulfolobus Solfataricus (Sso AcP) (69), the N-terminal 
domain of the hydrogenase maturation factor from Escherichia Coli (HypF-N) 
(70). Protofibrils can be both on-pathway to fibrils (24,53) or off-pathway 
species that simply accumulate during amyloidogenesis (68,71). There is 
evidence that not only mature fibrils but also the oligomeric protofibrils share a 
number of structural features, regardless of the protein that originate them. This 
finding has also lead to the creation of a specific antibody able to recognize 
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protofibrillar material from different sources (72). The interesting remark is that 
this antibody does not recognize the corresponding monomers nor the fully 
fibrillar state of the protein, suggesting that the oligomeric states share some 
common epitopes on the surface that are lost with fibril formation. 
 
1.5 Native-like aggregation 
 
Aggregation of globular proteins can occur either via partial unfolding across 
the major free energy barrier of (un)folding, as well established in past years 
(73-76), or via a mechanism that implies the early formation of native-like 
oligomers (56,69,77,78). The partial unfolding theory has been the most 
accreditated for a considerable length of time, following the observation that in 
most cases the experimental conditions or mutations that promote aggregation 
also induce a destabilization of the protein native structure, up to the partial or 
complete loss of the native folding. Such experimental conditions are usually 
chemical or physical alterations of the solution, like high temperature, high 
pressure, low or high pH, moderate concentrations of organic co-solvents as 
fluoroalcohols (38,68,79-81). This “conformational change” hypothesis was 
supported also by the evidence that in some proteins, as human lysozyme, 
human transthyretin (TTR) and the N-terminal domain of the HypF protein of 
E. Coli (HypF-N), the aggregation process is promoted by amino acid 
substitutions that destabilize the native fold allowing the population of partially 
folded states (82,83). The need for unfolding, at least partial, is also supported 
by studies that have demonstrated that the addition of antibodies or specific 
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ligands stabilizing the native state, monomeric or oligomeric, impair 
aggregation (84-88). 
In the last years, a different hypothesis emerged to describe aggregation 
from initially folded proteins: a globular protein can aggregate from its native 
state without any need to unfold across the major free energy barrier, but just 
via structural fluctuations that normally occur under physiological conditions 
(Fig. 1.7) (17). For example, at low pH the S6 protein from Thermus Thermophilus 
converts very rapidly to a quasi-native state; a study performed on the kinetic 
properties of a set of mutants has shown that the longer lag phases in 
aggregation under these conditions correlate with faster rates of unfolding (56). 
This means that kinetic stability can control fibrillation, implying that the quasi-
native state, rather than the denatured state, is the species that participates in 
nucleation (56). Human insulin forms fibrils at low pH that are preceeded by 
the formation of oligomers in which the protein retains the native conformation 
rich in "-helices (77). In this process the extensive !-sheet content typical of 
amyloid appears only in a later phase (77). Another example, that is particularly 
relevant in relation to the present thesis work, is the case of the acylphosphatase 
from Sulfolobus Solfataricus (Sso AcP). This protein aggregates under conditions 
in which a native-like state is initially populated and forms, as a first step, 
aggregates in which the monomers maintain their native-like topology (69,78). 
The unstructured 11-residue N-terminal segment and the edge !-strand-4 has 
been shown to play a major role in the process (89). Kinetic experiments on a set 
of Sso AcP variants revealed that the major event of the first aggregation step is 
the establishment of an inter-molecular interaction between the unstructured 
segment of one Sso AcP molecule and the globular unit of another (90).  
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Figure 1.7 A schematic representation of some of the many conformational states that can be 
adopted by polypeptide chains and of the means by which they can be interconverted. The 
transition from !-structured aggregates to amyloid fibrils can occur by addition of either 
monomers or protofibrils (depending on protein) to preformed !-aggregates. Figure and 
caption adapted from (17). 
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In a subsequent step these initial aggregates convert into !-sheet containing and 
ThT-/Congo Red positive amyloid-like protofibrils, via a structural 
reorganization process in which the individual Sso AcP molecules undergo an 
intramolecular conformational rearrangement (69,78,89). 
 
1.6 The Acylphosphatase-like structural family: structure 
and function  
 
1.6.1 The acylphosphatase-like family  
In this thesis I focus my attention on proteins belonging to the acylphosphatase-
like structural family, mainly the acylphosphatase from Sulfolobus solfataricus 
(Sso AcP) and the acylphosphatase 2 from Drosophila Melanogaster (AcP Dro2). 
In chapter V, for comparison purposes, I will also analyze some features of the 
acylphosphatase from human muscle (mt AcP) and the N-terminal domain of 
the HypF protein from E. Coli (HypF-N).  
 Acylphosphatase (AcP) is a small, about 100 residue long, "+! protein 
belonging to the ferredoxin-like fold (Fig. 1.8). The structure of the protein is 
highly conserved throughout the family. All the AcPs so far characterised show 
the same !"!!"! topology that originates from an antiparallel !-sheet docking 
against two antiparallel "-helices (Fig. 1.8) (91-94).  
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Figure 1.8 The structure of some members of the acylphosphatase-like structural family. From 
left to right: AcP from Homo Sapiens (muscular type, PDB entry 1APS), HypF-N from Escherichia 
Coli (PDB entry 1GXT), AcP 2 from Drosophila Melanogaster (PDB entry 1URR) and AcP from 
Sulfolobus solfataricus (PDB entry 1Y9O). 
 
 AcP is a widely diffused enzyme (enzyme commission 3.6.1.7) able to 
hydrolyze acylphosphates, with formation of a phosphate ion and a carboxylate 
group (95) . The mechanism of catalysis has been studied in detail in mt AcP 
(96-98). The catalytic residues are an Arginine and an Asparagine residues 
which are highly conserved within the family. The catalytic activity requires the 
presence of both residues cited above and a water molecule that is used to start 
the nucleophilic reaction that leads to the hydrolysis. In particular, the Arginine 
residue has been shown to be the main phosphate binding residue (98), while 
the Asparagine is known to bind the water molecule and catalyze the 
hydrolysis reaction (97). Analysis of the crystal structure of both the muscular 
(mt AcP) and common-type AcP (ctAcP) displayed that the side chain of this 
Arginine, namely Arg23, is in close spatial proximity with the side chain of the 
prevoiusly cited Asparagine (Asn41) and with the 15-21 loop, a small mobile 
region highly conserved among the different isoforms (92,99). A mutational 
analysis of the loop resulted in an impairment of the binding capacity and a 
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wrong positioning of the substrate, leading to a loss of catalytic activity (96). 
 The precise physiological function of AcP in the various organisms is not 
clear, although different functions have been suggested for this protein. Some 
authors proposed a role in regulation of membrane transport, relying on the 
ability of AcP to hydrolyse the !-aspartyl-phosphate forming during the action 
of membrane pumps (100); others showed the ability of AcP to induce 
apoptosis in HeLa cells (101) and also undergo a nuclear migration and interact 
with other DNAses in response to various apoptotic stimuli (102). Finally, since 
the AcP levels increase in several cell lines during differentiation and AcP is 
able to hydrolyse both # and ! phosphate groups of ATP, it was proposed a role 
for AcP in regulation of differentiation through a control of the ATP and ADP 
levels (103). 
 
1.6.2 Folding and aggregation in the acylphosphatase-like family  
In the last years AcPs have been largely used as models for both folding and 
amyloid-like aggregation studies. The folding process shows high variability in 
the acylphosphatase-like family. The first comparisons were made between the 
two human isoforms, mtAcP and ctAcP, ad it was shown that ctAcP bears a 
lower conformational stability than mt AcP, although its folding rate is greatly 
higher than that of mt AcP, suggesting no correlation between folding rate and 
conformational stability within the AcP family (104,105). 
 In addition, both the folding processes of Sso AcP, HypF-N from E. coli 
and AcP from E. coli have been characterised in some detail (106-108). These 
studies, carried out on structurally related but evolutionary distant proteins, 
allowed some important parameters for folding to be identified (106-108). 
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Indeed, correlations within the acylphosphatase-like family indicate 
hydrophobicity, relative contact order, "-helical propensity and disulfide 
bridges as important determinants of folding rate (106-109) . 
 The processes of amyloid aggregation for different AcPs have also been 
studied. Interestingly, in spite of the common structural features they share, 
different AcPs can undergo aggregation starting from different conformational 
states. In the case of mt AcP and HypF-N, it was shown that a partial unfolding 
is required to initiate the process (35,110), while Sso AcP can form amyloid 
fibrils starting from a native-like state (69,78,89,90). In the latter case, as 
mentioned in the previous section 1.4, two types of prefibrillar aggregates have 
been found. Aggregation results initially in the formation of oligomers with a 
small content of !-sheet structure, no ThT, Congo Red or ANS binding and, 
remarkably, enzymatic activity. Later on, oligomers with characteristics 
reminiscent of amyloid protofibrils will form, with the latter originating from 
the structural reorganization of the initial assemblies. These species consist in 
spherical or chain-like protofibrils with extensive !-sheet structure, ThT, Congo 
Red and ANS binding and no enzymatic activity. 
 
1.7 Aim of the thesis 
 
The scope of this thesis  is to study in further detail the native-like aggregation 
process using Sso AcP and a novel AcP that has not been studied before, 
namely the isoform 2 of acylphosphatase from Drosophila Melanogaster. 
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The first part of the thesis describes the process of amyloid fibril 
formation of the acylphosphatase 2 of D. Melanogaster (AcPDro2), previously 
cloned and purified as described (111). We found that this protein is able to 
form amyloid-like fibrils under conditions in which the conformational stability 
of its native state is unchanged. The results of this study have been published 
(112). 
The second part of the thesis was aimed at testing the effects of specific 
ligands binding to the active site on the aggregation behaviour of AcPDro2 and 
Sso AcP, i.e. proteins in which amyloid formation starts from a native-like state. 
For the study performed on SsoAcP I am greatly indebted with dr. Georgia 
Plakoutsi, who made the measurements. The results of this part of the work 
have been published (113). 
Finally, the last part of the work presented in this thesis stemmed from a 
theoretical comparative inspection of the structures of the four AcPs for which 
the aggregation process has been studied in some detail, namely Sso AcP, 
AcPDro2, HypF-N and mtAcP. This analysis provided clues to the 
identification of the factors determining either aggregation via unfolding or 
native-like aggregation and was coupled with a specific mutational analysis of 
the edge !-strand-4 of SsoAcP to convert the aggregation pathway from one to 
other mechanism. The results of this study have been published (114).  
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CHAPTER II – MATERIALS AND METHODS 
 
2.1 Protein cloning, mutagenesis and expression  
 
2.1.1 Cloning of the wild-type AcPDro2 and Sso AcP gene in pGEX vectors 
The genes coding for AcPDro2 and Sso AcP were cloned in pGEX-4T1 and 
pGEX-2T plasmids, respectively (GE Healthcare Life Sciences, formerly 
Amersham Biosciences, Uppsala, Sweden). The genes were amplified by 
polymerase chain reaction (PCR) using suitable primers containing the 
restriction sites for XhoI and EcoRI (for AcPDro2), and for BamHI and EcoRI (for 
Sso AcP), respectively (New England 
Biolabs, Ipswich, Massachusetts). The 
fragments resulting from PCR 
amplification were digested with the 
corresponding restriction enzymes and 
then ligated into pGEX vectors (Figure 
2.1) previously digested with the same 
endonucleases.  
 
 
Figure 2.1. Map of the pGEX vectors. GST fusion proteins are constructed by inserting a gene 
or gene fragment into the multiple cloning site. Expression is under the control of the tac 
promoter, which is induced by the lactose analog isopropyl !-D thiogalactoside (IPTG). The 
vectors is also engineered with an internal lacIq gene. The lacIq gene product is a repressor 
protein that binds to the operator region of the tac promoter, preventing expression until 
induction by IPTG, thus maintaining tight control over expression of the insert. 
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In the ligated plasmid the protein sequence is inserted downstream and in 
frame with glutathione S-transferase (GST) resulting in a fusion protein of 
approximately 37 kDa. At the junction site of the two proteins there is the 
recognition and cleavage sequence of the protease Thrombin (Sigma-Aldrich, 
Saint Louis, Missouri). The plasmid resulting from the cloning procedure was 
checked by DNA sequencing. 
 
2.1.2 Site-directed mutagenesis 
The mutated genes of AcPDro2 and Sso AcP were created with the 
QuickChange site-directed mutagenesis kit from Stratagene (La Jolla, 
California), using specifically designed primers containing the desired 
mutations (purchased from MWG Biotech, Firenze). The PCR reaction 
generated a mutated plasmid that was then treated with DpnI endonuclease (1h 
at 37 °C). This enzyme specifically digesting methylated DNA selectively cuts 
the non-mutated parental DNA template. Finally, the digestion mix has been 
transformed into E. coli XL1-Blue supercompetent cells. The successfully 
transformed cells were then selected by growing the transformation mix in the 
presence of a specific antibiotic. The presence of the desired mutation was 
assessed by sequencing the entire gene. 
 
2.1.3 Protein expression and purification from pGEX vectors 
Cultures of E. coli XL1-Blue cells harbouring the plasmid were grown overnight 
at 37 °C in LB medium supplemented with 100 µg/ml ampicillin with vigorous 
shaking. These were then diluted (1:50) in fresh LB medium and grown until 
the OD600 reached approximately 0.6 under the same conditions. Protein 
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expression was induced for 2-3h at 37 °C using 0.2 mM isopropyl-!-D-
thiogalactoside (IPTG). The induced cells were harvested by centrifugation and 
the pellet was resuspended in PBS buffer (20 mM NaH2PO4, 250 mM NaCl, pH 
7.3, containing 1mM EDTA, 1 mM !-mercaptoethanol), and freezed to -20°C 
overnight or more. Cells were then lysed using 1.0 mg ml-1 lysozyme (30 min in 
ice under agitation) followed by 5-6 cycles of 30 s sonication at 20 kHz and 
100W with 30 s cooling period between each burst. The supernatant obtained 
after a centrifugation step (40 min, 16000 rpm, 4 °C) that contains the soluble 
proteins, was applied on an affinity chromatography column (glutathione-
agarose resin, from Sigma) equilibrated in the same buffer. Cleavage of the 
fusion protein bound to the resin was performed in 50 mM Tris-HCl buffer, 
pH8.0, containing 150 mM NaCl, by overnight incubation at 4 °C with bovine 
Thrombin (50 units). The Thrombin digestion yields a protein with an extra 
glycine-serine dipeptide at the N-terminal that originates from its cleavage site. 
The protein eluted from the column in Tris-HCl buffer was subsequently 
exchanged to the storage buffer (see section 2.1.5) by ultrafiltration (YM 
membrane, 3000 Da MW cut-off, Millipore).  
 
2.1.4 Determination of protein purity and concentration 
Protein purity was checked by SDS-PAGE. The final protein concentration was 
calculated from absorption measurements at 280 nm, using $280 values of 1.09 
and 1.24 ml mg-1 cm-1 for AcPDro2 and Sso AcP, respectively. $280 values were 
obtained using the ProtParam application available on the ExPASy Proteomics 
server (www.expasy.org) 
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2.1.5 Protein storage  
AcPDro2 was stored in 50 mM acetate buffer, 2 mM DTT, pH 5.5. Sso AcP was 
stored in 10 mM Tris-HCl, pH 8.0. Before starting each experiment, each protein 
solution was centrifuged at 18000 rpm for 3-5 minutes, filtered using 0.02 !m 
Anotop 10 filters (Whatman International Ltd, Maidstone, UK), and the protein 
concentration was re-determined spectrophotometrically. 
 
2.2 Dye binding assays 
 
2.2.1 Congo Red absorbance 
Congo Red is a diazole dye that binds amyloid proteins with a relatively high 
specificity. This binding has been shown to depend on the secondary 
conformation of amyloid, and specifically the !-sheet conformation (115). When 
Congo Red binds to amyloid, its absorption peak undergo a marked red shift, 
from 490 to 540 nm (116). 
AcPDro2 was incubated at a concentration of 0.4 mg ml-1 for approximately 60 
hours in 50 mM acetate buffer, 2 mM DTT, pH 5.5, 25°C, in the presence of 0 or 
5% (v/v) trifluoroethanol (TFE). In both cases a 60 !l aliquot was mixed with a 
440 !l solution containing 20 !M CR, 5 mM phosphate buffer, 150 mM NaCl, 
pH 7.4, in a reduced volume, 5 mm path lenght quartz cuvette. Corresponding 
solutions of CR without protein and protein with no CR were used as controls. 
Optical absorption spectra were acquired from 400 to 700 nm by an Ultrospec 
2000 spectrophotometer (Pharmacia Biotech, Cambridge, UK.). The spectrum 
obtained with buffer only was subtracted from all acquired spectra. 
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2.2.2 Thioflavin T fluorescence 
The fluorescent dye Thioflavin T (ThT) is a benzothiazole dye able to bind 
selectively to amyloid aggregates, probably through ionic and hydrophobic 
interactions (117-119). Following this binding the fluorescence emission of ThT 
shows an increased maximum around 485 nm that can be easily monitored. 
Recent studies showed that ThT binds in a specific regular fashion to amyloid 
fibrils such that their long axes run parallel (118). It has been proposed that the 
binding occurs in “channels” along the length of the !-sheet structure of 
protofilaments (Fig. 2.2).  
Figure 2.2 Schematic representation of the 
possible mechanism of interaction between 
Thioflavin T and a !-sheet. The major axis of 
the dye can fit in a possible “binding channel” 
of the !-sheet. From (118). 
 
In a first set of experiments, described in Chapter III, AcPDro2 was incubated at 
a concentration of 0.4 mg ml-1 in 50 mM acetate buffer, 2 mM DTT, pH 5.5, 25°C 
in the presence of concentrations of TFE ranging from 0 to 20% (v/v). At 
regular times 60 !l aliquots of each sample were added to 440 !l of a solution 
containing 25 !M ThT, 25 mM phosphate buffer, pH 6.0. The steady-state 
fluorescence values of the resulting samples were measured at 25°C using a 
2x10 mm path length quartz cuvette and a Perkin-Elmer LS 55 
spectrofluorimeter (Wellesley, Massachusetts) equipped with a thermostated 
cell holder attached to a Haake F8 water bath (Karlsruhe, Germany). The 
excitation and emission wavelengths were 440 and 485 nm, respectively.  
Another set of data was collected after incubating the protein in 50 mM 
formiate buffer, 5% (v/v) TFE, 25 mM NaCl, 2 mM DTT, pH 3.5, 25°C. 
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In the experiments described in Chapter IV, AcPDro2 and Sso AcP were 
incubated at concentrations of 0.4 mg ml-1 in 50 mM acetate buffer, 2 mM DTT, 
pH 5.5, 25 °C, containing Pi at a concentration ranging from 0 to 10 mM and TFE 
(10 and 20% (v/v) TFE for AcPDro2 and Sso AcP, respectively). At regular 
times 60 !l aliquots of each sample were added to 440 !l of a solution 
containing 25 !M ThT, 25 mM phosphate buffer, pH 6.0. The steady-state 
fluorescence values of the resulting samples were measured at 25°C using the 
same equipment described above. All measured fluorescence values are given 
after subtracting the fluorescence measured in the absence of protein and 
normalised so that the final fluorescence at the endpoint of the kinetic trace was 
100%.  
Finally, in the experiments reported in Chapter V, all variants of Sso AcP 
were incubated at concentrations of 0.4 mg ml-1 in 50 mM acetate buffer, pH 5.5, 
25 °C, in the presence of 3%, 10% or 20% (v/v) TFE. Measurements were 
performed as described above.  
 
2.2.3 ANS fluorescence 
1-anilino-8-naphtalenesulfonic acid (ANS) is an amphiphilic dye that is able to 
bind to exposed clustered hydrophobic residues of a polypeptide chain (120). 
Binding is non-covalent and involves a combination of hydrophobic and 
electrostatic interactions, the latter depending on a strong ability to bind 
cationic groups (121) . The fluorescence emission of this molecule undergoes a 
blue shift and strong enhancement when its exposure to water is decreased. 
Consequently, fluorescence of ANS increases substantially when proteins to 
which it is bound undergo transitions from unfolded to fully or partially folded 
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states that provide shielding from water (122). 
In the experiments performed during this thesis, AcPDro2 was diluted to a final 
concentration of 0.02 mg ml-1 in 55 µM ANS, 50 mM acetate, 2 mM DTT, pH 5.5, 
25°C. We prepared two samples containing 0 and 5% TFE, respectively. 
Fluorescence spectra were acquired immediately after dilution using the same 
cell and equipment described under the ThT assay paragraph. Excitation 
wavelength was set at 380 nm and  emission range was from 410 to 630 nm. 
Spectra were also acquired for the corresponding solutions in the absence of 
protein. Each spectrum was the average of two scans and was smoothed using a 
moving average function with the statistical mean of seven points. ANS 
concentration was determined spectrophotometrically using an $375 value of 
8000 ml mmol-1 cm-1. 
 
2.3 Enzymatic activity assay 
 
The enzymatic activity of the acylphosphatases used for these studies has been 
measured monitoring the absorbance of the reaction substrate. The absorbance 
decay was followed at 283 nm using benzoylphosphate as substrate, as 
previously well described for other acylphosphatases (97,123). Activity was 
measured with a Perkin-Elmer % 4 B UV-Vis spectrophotometer (Wellesley, 
Massachusetts). The non-catalyzed spontaneous hydrolysis of 
benzoylphosphate was subtracted from all measurements.  
In the experiments described in Chapter III, the enzymatic activity of AcPDro2 
was tested in the presence of TFE concentrations ranging from 0 to 5%, using a 
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final protein concentration of 0.5 !g ml-1 and 4 mM benzoylphosphate. Other 
experimental conditions were 50 mM acetate buffer, 2 mM DTT, pH 5.5, 25°C. 
Measurements were performed immediately after addition of TFE, without any 
incubation time.  
In the experiments reported in Chapter V, the enzymatic activity of Sso 
AcP and its mutants was tested using a final protein concentration of 0.5 !g ml-1 
and 4 mM benzoylphosphate. Other experimental conditions were the same as 
in the previous set of experiments. 
 
2.4 Intrinsic fluorescence measurements 
 
2.4.1 Theory 
Some atoms and molecules, called fluorochromes, are able to absorb light at a 
well defined wavelength and then to emit light of longer wavelength. For any 
molecule, several different electronic states exist, each subdivided into a 
number of vibrational and rotational energy levels (shown as S0, S1… Sn in Fig. 
2.3). When common fluorophores are irradiated with ultraviolet or visible light, 
they absorb energy and are excited to a higher vibrational level. After energy 
absorption, molecules remain in the excited state for approximately 10-9 
seconds, and then return to ground state with a process called relaxation. There 
are many different ways in which an excited molecule can return to ground 
state. If the photon emission occurs between two energy levels with the same 
spin, as illustrated in fig. 2.3 (e.g. S1 and S0) the phenomenon is called 
fluorescence. Instead, if the spin states of the levels are different (e.g. from T1 to 
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S0), the emission is called phosphorescence. Fluorescence is much more likely 
to occur than phosphorescence for most molecules, but the lifetime of 
fluorescent states is very short (from 10-5 to 10-8 seconds). The emitted photons 
have less energy with respect to exciting ones, and so the emission spectrum is 
shifted to longer wavelengths. 
 
Figure 2.3 Jablonski energy 
diagram.  
 
Fig.2.3 shows also some 
relaxation processes, 
called nonradiative, in 
which there isn’t any 
light emission: internal 
conversion (IC) and 
intersystem crossing (ISC). Internal conversion is a transition between energy 
states of the same spin, similar to fluorescence but without light radiation, 
occurring in 10-12 seconds or less. Intersystem crossing is a transition between 
different spin states, comparable to phosphorescence but radiationless, 
occurring in 10-9 seconds.  
 Fluorescence is generally associated with highly conjugated polycyclic 
aromatic molecules. The aromatic side chain amino acids that are present in 
polypeptide chains (Trp, Tyr, Phe) confer them the ability to emit fluorescence 
when excited. In proteins, about the 90% of the fluorescence emission is given 
by Trp side chains. Considering that Trp fluorescence is highly influenced by its 
close environment, it is possible to follow changes in protein conformation, 
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stability, substrate binding, etc., monitoring the protein fluorescence emission. 
For example, Trp side chains normally resides on the hydrophobic interior of 
proteins where the environment is relatively non-polar. Upon protein 
destabilization or even denaturation with heat or a chemical agent, the 
environment of the Trp aromatic ring changes, becoming more polar as the 
residue get in contact with the aqueous solution. This leads both to an increase 
in intensity of fluorescence emission and to a shift of the maximum peak from 
approximately 330 to 365 nm. 
 In some cases, it can be difficult to follow conformational transitions that 
reach the equilibrium very rapidly, because conventional fluorimeters require 
manual mixing that causes a delay of many seconds in measurements, while the 
transition process ends in few milliseconds. To follow a process from the very 
beginning one should use a fluorimeter coupled with a stopped-flow apparatus. 
Using this instrument, small volumes of solutions are pushed from two ore 
more syringes to a high efficiency mixer just a few milliseconds before passing 
into a measurement flow cell. The steady state equilibrium is reached during 
the solution flow. At a certain moment the flow is stopped and some of the 
flowing mixed solution remains trapped in the flow cell. As the reaction 
proceeds, the  kinetics can be followed by monitoring the fluorescence 
variations. Not even in this case the observation can start at the time zero of the 
reaction, but there is a short dead time that is the time needed from the solution 
to reach the middle of the cell from the last mixing point. The dead time is 
dependent on the volume from the last mixing point to the center of the 
observation area (dead volume) and on the total flow rate through the cell 
corresponding to the sum of the flow rate set on the syringes.  
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For the rapid kinetic experiments described in this thesis I used a fluorimeter 
equipped with the Bio-logic SFM-3 
stopped-flow apparatus (Claix, France). 
The latter handles three stainless steel 
syringes driven by independent 
stepping motors and two mixing 
chambers (Fig. 2.4).  
 
Figure 2.4 Schematic representation of a 
stopped-flow apparatus 
 
The first mixing chamber is situated after the syringes 1 and 2. After this comes 
a delay line whose volume determines the time constant. The second mixing 
chamber is found at the end of the delay line, mixing the solution coming from 
the mixer 1 with that from syringe 3. Then, the liquid is filled in the observation 
cell. Volumes and mixing times are computer controlled. 
 
2.4.2 Intrinsic fluorescence spectra 
To follow the effect of chemical denaturants on the structural packing, AcPDro2 
was diluted to a final concentration of 0.02 mg ml-1 in 5 mM acetate, 2 mM DTT, 
pH 5.5, 25°C and in the presence of various denaturants. Fluorescence spectra 
were acquired immediately after dilution using the cuvette and instrumental 
apparatus described under the ThT assay paragraph. Excitation wavelength was 
set at 280 nm and emission range was from 300 to 450 nm. Each spectrum was 
recorded as the average of two scans and smoothed using a moving average 
function with the statistical mean of seven points. 
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2.4.3 Equilibrium unfolding 
Unfolding of AcPDro2 was studied at equilibrium in the presence of different 
concentrations of TFE, ranging from 0 to 5% (v/v). For each TFE concentration 
30 samples were prepared containing 0.02 mg ml-1 protein in 50 mM acetate 
buffer, 2 mM DTT, pH 5.5, and various urea concentrations ranging from 0.1 to 
8 M. The samples were left to equilibrate for a few minutes at 25°C. 
Fluorescence spectra were acquired at 25°C using the cuvette and instrumental 
apparatus described under the ThT assay paragraph, with a wavelength range 
between 300 and 450 nm and an excitation wavelength at 280 nm. Each 
spectrum was recorded as the average of two scans and smoothed using a 
moving average function with the statistical mean of seven points. The 
fluorescence at 348 nm was plotted versus urea concentration and the resulting 
plot was fitted to the equation described by Santoro and Bolen (124) to 
determine the free energy difference between the unfolded and folded states of 
the protein in the absence of urea ("G
U#F
H
2
O ), the dependence of "G
U#F
 on urea 
concentration (m value) and the midpoint of unfolding (C
m
). 
The monitoring of the degree of unfolding at equilibrium has been also 
performed using the far-UV circular dichroism technique (see section 2.5). 
 
2.4.4 Folding and unfolding kinetics 
For the experiments described in Chapter III, unfolding and refolding of 
AcPDro2 were followed with the Bio-logic SFM-3 stopped-flow device, coupled 
to a fluorescence detection system, as described in section 2.4.1. The flow cell 
was thermostated at 25°C with a Neslab RTE-200 water-circulating bath 
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(Newington, New Hampshire). The excitation wavelength was 280 nm, and the 
fluorescence emitted above 320 nm was monitored using a bandpass filter. All 
the experiments were performed in 50 mM acetate, 2 mM DTT, pH 5.5, at a final 
protein concentration of 0.02 mg ml-1. In a first set of unfolding and folding 
experiments the protein was initially in 0 and 6 M urea, respectively. Both 
reactions were initiated by ten fold dilutions. Unfolding and folding kinetics 
were studied at final urea concentrations of 5.4 and 0.6 M, respectively, in the 
presence of TFE concentrations ranging from 0 to 8.25% (v/v). The dead-time 
was 10.44 ms. The unfolding and refolding traces were fitted to single and 
double exponential functions, respectively (see Equation A in chapter III). In a 
second set of experiments, the unfolding and refolding kinetics were monitored 
at final urea concentrations ranging from 1.80 M to 7.20 M for unfolding and 
from 0.50 M to 3.20 M for folding. Finally, in a third set of experiments the 
protein was unfolded in 2 M urea, 10 mM trifluoroacetic acid (TFA), pH 2.0. 
Folding was initiated by a 20 fold dilution in 50 mm acetate buffer, pH 5.5, 2 
mm DTT, 25°C, at final urea concentrations ranging from 0.1 to 1.8 M. These 
experiments were performed both in 0% and 5% (v/v) TFE. In these second and 
third sets of experiments the analysis was carried out at final TFE 
concentrations of 0 and 5% (v/v). The unfolding and refolding traces were 
fitted to an exponential function (Equation E) and the natural logarithm of ki 
was plotted versus urea concentration for both the analyses carried out in 0 and 
5% TFE. The resulting plots were fitted using the equation edited by Jackson 
and Fersht (125). (see Equation B in Chapter III). 
For the experiments described in Chapter V, unfolding and refolding 
kinetics of Sso AcP and its mutants were studied with the same device but 
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thermostated at 37 °C. Unfolding kinetics were monitored by preparing a 
protein sample at 0.4 mg ml-1 in 10 mM Tris/HCl, pH 8.0 and by a twenty fold 
dilution into solutions containing 50 mM acetate buffer, pH 5.5 and various 
guanidine hydrochloride (GdnHCl) concentrations. In refolding experiments all 
protein variants, except wild-type, were initially unfolded in 5 M GdnHCl, 10 
mM Tris/HCl pH 8, whereas wild type was unfolded in 6 M GdnHCl, 10 mM 
Tris/HCl pH 8. Reactions were started by a twenty fold dilution into solutions 
containing 50 mM acetate buffer, pH 5.5 and small GdnHCl concentrations. 
Unfolding and refolding kinetics were monitored at final protein concentration 
of 0.02 mg ml-1, final GdnHCl concentrations ranging from 1.90 M to 7.60 M for 
unfolding and from 0.30 M to 3.90 M for refolding. These experiments were 
performed both in the absence and in the presence of 3% (v/v) TFE for all 
variants, except Y86E, for which a 10 % (v/v) TFE concentration was also used. 
The dead-time was 10.44 ms. The recorded traces were fitted to exponential 
functions (Equation A) and the natural logarithm of k
i
 was plotted versus 
GdnHCl concentration for each variant and for each TFE concentration used. In 
each case, the unfolding and refolding data from these plots were analyzed 
separately with a best fitting procedure using a linear and a 2nd order 
polynomial function, respectively. This allowed the values of folding rate 
constant from a partially folded state ( k
I "F
H
2
O ) and unfolding rate constant ( k
F"U
H
2
O ) 
to be extrapolated in the absence of GdnHCl from the lines of best fit.  
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2.5 Circular dichroism measurements 
 
2.5.1 Theory 
Circular dichroism (CD) spectroscopy is a form of light absorption spectroscopy 
that measures the difference in absorbance of right- and left-circularly polarized 
light by a substance. Unlike in isotropic light, in which the electric field vector 
oscillates uniformly in all directions, in linearly polarized light the magnitude 
of its electric field vector oscillates only in one plane, similar to a sine wave. In 
circularly polarized light, the electric field vector has a constant length, but 
rotates about its propagation direction. Hence, it forms a helix in space while 
propagating (Fig. 2.5). If this is a left-handed helix, the light is called “left 
circularly polarized”, 
and viceversa for a right-
handed helix.  
 
 
Figure 2.5 Linearly and circularly polarized light 
 
Circularly polarized light interacts differently with chiral molecules, because 
the two types of circularly polarized light are absorbed to different extents. In a 
CD experiment, equal amounts of left and right circularly polarized light of a 
selected wavelength are alternately radiated into a sample (Fig. 2.6). If the 
sample is optically active, i.e. chiral, one of the two polarized beams is absorbed 
more than the other, and this difference of absorption is measured in 
dependence of wavelength, giving the CD spectrum of the sample. For the 
experiments reported in this thesis, a Jasco J-810 spectropolarimeter (Tokyo, 
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Japan) equipped with a 
thermostated cell holder 
attached to a Thermo Haake 
C25P water bath (Karlsruhe, 
Germany) was used. 
 
 
Figure 2.6 Schematic drawing of a 
spectropolarimeter 
 
Chromophores are optically active groups within the protein: backbone amide 
bonds, disulphide bonds, and aromatic side chains such as Phe, Trp, and, to a 
lesser extent, Tyr. In secondary structure conformations, the backbone and 
hence the amide bond chromophores are arranged in regular organized 
patterns. CD spectroscopy is extremely sensitive to these patterns and each 
conformation gives rise to characteristic spectral features. Random coil has a 
positive band at 212 nm and a negative 
one at around 195 nm; !-sheet shows a 
negative band at 218 nm (& ' &* 
transition) and a positive one at 196 nm (n 
' &*); !-helix has two negative bands at 
222 nm (n ' &*) and 206 nm (& ' &*) and 
a positive band (& ' &*) at 190 nm (126). 
 
Figure 2.7 Circular dichroism spectra of various “pure” secondary structure: !-helix (black), !-
sheet (red), type-1 turn (green), random coil (yellow) and poly-L-proline (blue). 
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The far-UV CD spectrum of proteins can reveal important characteristics of 
their secondary structure. CD spectra can be used to estimate the fraction of a 
protein that is in each secondary structure conformation: "-helix, !-sheet, !-
turn, random coil etc. (127). It can be also used to study how the secondary 
structure of a protein changes as a function of pH, temperature or concentration 
of denaturing agents, e.g. trifluoroethanol, urea or guanidinium hydrochloride.  
The near-UV CD spectrum (>250 nm) of proteins provides information on the 
tertiary structure. The signals obtained in the 250-350 nm region are due to the 
absorption, dipole orientation and the nature of the surrounding environment 
of the phenylalanine, tyrosine, cysteine (or S-S disulfide bridges) and 
tryptophan amino acids. Unlike in far-UV CD, the near-UV CD spectrum 
cannot be assigned to any particular 3D structure.  
 
2.5.2 Far-UV  
For the experiments described in Chapter III , samples of AcPDro2 were 
prepared at final concentrations ranging from 0.01 to 0.8 mg ml-1 in 5 mM 
acetate buffer, 2 mM DTT, pH 5.5, 25°C, in the presence of 0%-5% and 80% TFE, 
or 5 M urea with no TFE. Far-UV CD spectra were acquired at 25°C 
immediately after diluting the stocked protein sample into these solutions. 
Quartz cuvettes with path lengths ranging from 1 to 10 mm were used 
depending on protein concentrations. Each spectrum of the protein was 
recorded from 190 to 260 nm as the average of four scans, blank-subtracted, 
processed using the adaptive smoothing method (128) and normalised to mean 
residue ellipticity. 
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For the experiments described in Chapter IV, the aggregation process of 
Sso AcP was started by incubating the protein, at a concentration of 0.4 mg ml-1, 
in 20% (v/v) TFE, 50 mM acetate buffer, pH 5.5, 25 °C, in the presence of 0-10 
mM Pi. Each kinetic trace was processed as described above for CD spectra.  
For the experiments described in Chapter V, far-UV spectra were first 
acquired, for all variants, under conditions in which Sso AcP has a native 
structure, i.e. in 10 mM Tris/HCl buffer, pH 8.0, 25 °C, at a protein 
concentration of 0.2 mg ml-1, using a 1 mm path length quartz cuvette. Spectra 
result from 10 accumulations. Far-UV CD spectra were also acquired under 
conditions promoting aggregation, in 50 mM acetate buffer, pH 5.5, 25 °C, in 
the presence of the TFE concentration reported in the text, at a protein 
concentration of 0.4 mg ml-1. In this case spectra were acquired immediately 
after addition of TFE. In another experimental set, the far-UV CD signal at 208 
nm was followed to monitor the first phase of aggregation. Samples were 
prepared by diluting protein stock solution in 50 mM acetate, pH 5.5, 25 °C, 3-
20% (v/v) TFE, at a final protein concentration of 0.4 mg ml-1. The same cuvette 
described above was used.  
Circular dichroism was also used to study the degree of unfolding at 
equilibrium in presence of denaturants. For the experiments described in 
Chapter IV, unfolding of AcPDro2 was studied at equilibrium in the presence of 
different concentrations of Pi, ranging from 0 to 10 mM. For each Pi 
concentration, 25-30 samples were prepared containing 0.02 mg ml-1 protein in 
50 mM acetate buffer, 2 mM DTT, pH 5.5, and various urea concentrations 
ranging from 0.1 to 8 M. The samples were left to equilibrate for a few minutes 
at 25 °C. Far-UV CD spectra were acquired at 25 °C using the apparatus 
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described in the previous paragraph and processed using the adaptive 
smoothing method (128). The ellipticity at 222 nm was plotted versus urea 
concentration and the resulting plot was fitted to the equation described in 
(124). 
For the experiments described in Chapter V, the conformational stability 
of each Sso AcP variant was studied at equilibrium by preparing 25-30 samples 
containing 0.02 mg ml-1 protein, 50 mM acetate buffer, pH 5.5, and various 
GdnHCl concentrations ranging from 0 to 8 M. The samples were left to 
equilibrate for 10 minutes at 37 °C. The ellipticity at 222 nm was acquired using 
the CD apparatus described above. Ellipticity values were plotted versus 
GdnHCl concentration. The resulting plot was fitted to the equation edited by 
Santoro and Bolen (124) to obtain CM and m values. The "GF#U
H
2
O  was calculated 
according to the equation "G
F#U
H
2
O
= C
M
$m , where m  is the average m value over 
a set of ca. 30 Sso AcP variants (data not shown). 
 
2.5.3 Near-UV 
Samples of AcPDro2 were prepared at final protein concentrations of 0.2 mg ml-
1 in 5 mM acetate buffer, 2 mM DTT, pH 5.5, 25°C, in the presence of 0% and 5% 
(v/v) TFE, or 4.5 M urea. Near-UV CD spectra were acquired at 25°C from 250 
to 350 nm, immediately after diluting the stocked protein sample into these 
solutions. A 10 mm path length quartz cuvette and the CD instrument 
described in the far-UV CD paragraph were used. Due to the low signal/noise 
ratio, spectra for the protein samples in 0% TFE and in 4.5 M urea were 
recorded as the average of 40 separate scans, while 10 scans were averaged for 
the protein sample in 5% TFE. Each spectrum was blank-subtracted, processed 
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using the adaptive smoothing method (128) and normalised to mean residue 
ellipticity. 
 
2.6 Dynamic Light Scattering 
 
2.6.1 Theory 
DLS measures the fluctuation of intensity of the light scattered from a sample 
containing particles subjected to Brownian motion. When a laser beam 
illuminates the sample, the particles in solution deviate some of the light waves 
in all directions and some of 
the scattered light hits a 
detector screen placed at an 
angle that can vary but is 
always different from 180° 
(Fig. 2.8).  
 
Figure 2.8 Schematic representation 
of a DLS measurement, showing the 
mechanism of scattering detection 
(upper panel) and examples of 
correlation functions. 
 
At any time the screen detector will show a so-called “interference pattern”. 
The name is due to the fact that the light intensity detected by the screen varies 
with relation to the phase interferences of the particles hitting it at a certain 
time: particles with the same phase interfere constructively and give a more 
intense light on the detector. The instrument determines the change in intensity 
of the interference pattern during time, using a digital correlator that measures 
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the degree of similarity (or correlation) between the interference pattern at time 
0 and that at a following time t. This is translated into a normalised correlation 
function, i.e. the correlation versus time. Figure 2.8 shows the correlation 
function for large and small particles. Large particles move slowly while small 
particles move quickly, such that the intensity of the speckle pattern will also 
fluctuate slowly and quickly, respectively. Therefore, the rate of decay for the 
correlation function will be related to particle size, as it is much faster for small 
particles than it is for large ones.  
All the experiments shown in this thesis were performed with a Zetasizer Nano 
S DLS device from Malvern Instruments (Malvern, Worcestershire, UK) 
thermostated with a Peltier system. 
 
2.6.2 Determination of the apparent hydrodynamic diameter 
For the experiments shown in Chapter III, samples were prepared at final 
AcPDro2 concentrations ranging from 0.3 to 1.0 mg ml-1 in 50 mM acetate 
buffer, 2 mM DTT, pH 5.5, 25°C, in the presence of 0% and 5% TFE. Each 
protein sample was prepared by diluting a stocked protein sample and was 
immediately centrifuged (18000 rpm for 5 min) and filtered (0.02 !m) shortly 
before acquiring its size distribution to remove any pre-existing aggregates and 
dust particles. A low volume (45 !l) black quartz cuvette with 10 mm light path 
was used.  
For the experiments shown in Chapter V, DLS measurements were 
performed at a protein concentration of 0.3 mg ml-1, in 50 mM acetate buffer, 
pH 5.5, 25 °C. In another experimental set the measurements were performed at 
0.4 mg ml-1 protein, after 2-3 hr incubation in 50 mM acetate buffer, pH 5.5, 25 
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°C, in the presence of 3-20% (v/v) TFE. Disposable plastic cuvettes with a 10 
mm light path (Plastibrand, Brand GMBH, Wertheim, Germany) were used. 
For all sets of measurements, data were obtained with the apparatus 
described in section 2.6.1, setting the appropriate viscosity and refractive index 
parameters for each solution and keeping the temperature at 25°C during the 
measurements by means of the thermostating system. 
 
2.7 Tapping Mode Atomic Force Microscopy 
 
The aggregate sizes reported in Chapter III were obtained from AcPDro2 
incubated at a concentration of 0.4 mg ml-1 in 50 mM acetate buffer, 5% (v/v) 
TFE, 2 mM DTT, pH 5.5, 25°C. Aliquots of 20 !l were withdrawn at various 
times, deposited on freshly cleaved mica substrates and dried under mild 
vacuum for 30 min. TM-AFM images were acquired in air using a Dimension 
3000 microscope (Digital Instruments, Veeco, Santa Barbara, California) 
equipped with a ‘G’ scanning head (maximum scan size 100 !m). Single beam 
uncoated silicon cantilevers were used (type RTESP, Veeco, Santa Barbara, 
California). The drive frequency was around 300 kHz; the scan rate was 
between 0.3 and 0.7 Hz. The aggregate sizes were obtained by measuring the 
aggregate height in cross section in the TM-AFM images. The apparent size 
deduced visually from the image turns out to be overestimated because of the 
broadening effect caused by the AFM tip in the scan plane (129). 
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The AFM measurements included in Chapter III of this thesis have been 
performed at the Department of Physics of the University of Genoa by Silvia 
Torrassa and Dr. Annalisa Relini. 
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CHAPTER III - RESULTS 
 
Characterization of a new isoform of acylphosphatase 
from D. Melanogaster (AcPDro2) and evaluation of its 
aggregation pathway. 
 
 
3.1 Introduction 
 
In some of the pathological conditions associated with formation of amyloid-
like structures the precursor protein is normally folded, in its soluble state, into 
a globular unit with persistent secondary structure and long-range interactions. 
Examples include !2-microglobulin, transthyretin, lysozyme, immunoglobulin 
light chain, superoxide dismutase, ataxin-3, cystatin c and gelsolin (21,130,131). 
Such proteins spend most of their lifetime in a folded state, but can transiently 
adopt a partially or totally unfolded state, for example during biosynthesis, 
translocation or stress conditions. Partially or totally unfolded states can also be 
in equilibrium with the native state even under non-stress conditions; this may 
provide a pool of protein molecules that can initiate and propagate the 
aggregation process, especially when the native structure is destabilised by 
mutations that shift the equilibrium towards the unfolded state (82,131). 
                                                                                                           Chapter III – Results  
48 
A major question that needs to be answered is whether amyloid formation is 
initiated by such partially or totally unfolded states that are only occasionally 
populated, or rather involve directly the native state. The observation that 
unfolded states have a greater propensity than folded states to aggregate and 
that amyloid formation is often associated with genetic mutations that can 
effectively destabilise the native state has led to the proposal that a 
conformational change is the first essential step in amyloidogenesis, at least for 
those diseases associated with such globular proteins (21,75,132). However, 
recent observations have questioned the generality of this mechanism. The 
pathogenic variant of ataxin-3, the protein associated with Spinocerebellar 
ataxia type-3, does not appear to have a destabilised native structure leading to 
the proposal that the pathway for fibril formation is distinct from that of 
unfolding (133). Amyloid formation by insulin is preceded by an 
oligomerisation of the protein in which a native-like content of "-helical 
structure is retained almost completely (77). Within a group of variants of the 
protein S6 from Thermus thermophilus, no significant correlation was found 
between the rate of fibril formation, under conditions in which a quasi-native 
state was populated prior to aggregation, and the unfolding rate or 
conformational stability (56). Aggregation of the acylphosphatase from 
Sulfolobus solfataricus into amyloid protofibrils is more rapid than unfolding 
under conditions in which the native state is thermodynamically more stable 
than the major partially unfolded state (69). All of these observations suggest 
that an association of protein molecules in their native-like states can be the first 
event in the aggregation of some globular proteins, with the structural 
conversion into an amyloid conformation occurring subsequently. 
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The study of amyloid formation under solution media in which the protein is 
initially in a native-like conformation is therefore of vital important to 
understand aggregation pathways that may potentially occur in vivo. Our 
ability to distinguish between mechanisms in which partial or full unfolding is 
a first step and others in which oligomerisation precedes a structural 
reorganisation is important not just to clarify the pathogenesis of specific 
protein deposition diseases, but also to recognise the dangerous pathways from 
which proteins generally need to escape to remain soluble in vivo.  
As previously described in Chapter I, all the model proteins used in this 
study belong to the Acylphosphatase superfamily; in particular, the first project 
was focused on the characterization of a novel acylphosphatase from Drosophila 
Melanogaster (fruit fly), a 102 residue protein domain having a ferredoxin-like 
topology in its native state, prevoiusly identified and cloned (111). Some years 
before, another Drosophila Melanogaster acylphosphatase (named AcPDro) was 
also characterized, as the product of a single exon in the Acyp gene located in 
2L chromosome. Since it was the most phylogenetically distant acylphosphatase 
that was characterized to the moment, it was considered as the possible 
common ancestor for MT and CT vertebrate isoenzymes (134). That hypotesis 
has been ruled out by the discovering of AcPDro2 and its characteristics. Coded 
by the CG18505 gene, namely Acyp2, this protein has been shown to be the 
product of a four-exon gene (while AcPDro is coded by a single exon), and is 
located on a different chromosome. The expressed and purified protein has 
been demonstrated to be a well folded enzyme, stable and with full catalytic 
activity, although the catalytic efficiency is lower than that of the vertebrate 
isoenzymes (111). The critical residues of the bovine CT AcP active site 
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(particularly Arg23 and Asn41) are conserved in AcPDro2, together with two 
active-site water molecules located in the region defined by the L1 and L3 loops 
and by the N-terminal region of the "1 helix (94).  
 
3.2 Formation of amyloid-like structures at low 
concentrations of TFE 
 
At the beginning of the project, the very first thing to evaluate was the potential 
tendency of the protein to aggregate. Since for other acylphosphatases the 
fluoroalcohol trifluoroethanol (TFE) have been shown to be effective in 
inducing aggregation, AcPDro2 was incubated at a concentration of 0.4 mg ml-1 
in 50 mM acetate buffer, 2 mM DTT, pH 5.5, 25°C at TFE concentrations ranging 
from 0 to 20 % (v/v). After 2 and 24 hours the protein samples were subjected 
to the ThT assay (119). All protein samples incubated at TFE concentrations 
higher than 4-5% (v/v) were able to increase significantly the fluorescence of 
ThT, while no significant aggregation was found to occur at lower TFE 
concentrations after 24 hr (Fig. 3.1). In 50% (v/v) TFE aggregation appears to be 
slightly lower than in 20%, with no significant differences in ThT binding after 2 
hours and 24 hours (data not shown). 
 
Figure 3.1 AcPDro aggregation measured by 
ThT fluorescence, after 2h (empty circles) and 
after 24h (full circles) of incubation in 0-20% TFE.  
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The protein samples incubated for 60 hours in 0 and 5% (v/v) TFE were 
also subjected to the CR assay (115). The spectra acquired for CR in the presence 
and absence of protein pre-incubated in buffer without TFE are superimposable 
(Fig. 3.2a). The difference spectrum, obtained by subtracting the spectra of 
protein only and CR only from the spectrum of CR with protein, does not show 
a peak at 540 nm, indicating that the protein is not able to bind to the dye and 
cause the characteristic red-shift from 490 to 540 nm (Fig. 3.2a, inset). By 
contrast, the spectrum acquired for CR in the presence of protein pre-incubated 
in 5% (v/v) TFE exhibited a significant red-shift relative to the spectrum of CR 
alone (Fig. 3.2b). The higher absorbance values found in the former at all 
wavelengths arises from the ability of the protein aggregates to scatter the 
incident light, as shown by the spectrum acquired for the protein only in the 
absence of CR (Fig. 3.2b). The difference spectrum, obtained as described above 
for the analysis in the absence of TFE, shows a peak at 540 nm, as expected for 
CR bound to ordered aggregates (Fig. 3.2b, inset). 
 
 
Figure 3.2 Congo Red assay on AcPDro2 aggregates. The protein was preincubated for (60h in 
two separate samples containing no TFE (a) and 5% TFE (b). Spectra were acquired for protein 
in phosphate buffer (triangles, sp. 1), Congo Red (circles, sp.2) and protein in CR-phosphate 
buffer (squares, sp.3). The insets shows the respective difference spectra, obtained subtracting 
spectra 1 and 2 from spctrum 3. 
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Secondary structure of the aggregates was monitored using far-UV CD 
(Fig. 3.3). Spectra were acquired using two sets of protein samples, each at 0.1, 
0.2 and 0.4 mg ml-1 in 5% (v/v) TFE. While the first set was pre-incubated for 48 
hours, the other was tested immediately after the addition of TFE. The CD 
spectra of the aggregated protein are significantly different from those obtained 
immediately after the addition of TFE when the aggregates are not yet present 
(Fig. 3). This indicates that a conformational change is associated with AcPDro2 
aggregation. The CD spectra of the aggregated protein display a single 
minimum at ca. 220-224 nm, typical of aggregates having !-sheet structure 
(135). The peak is generally at 215-218 nm, but undergoes a red-shift due to 
light scattering phenomena arising from the aggregates. 
 
Figure 3.3 Far-UV CD spectra of AcPDro2 in 
5% TFE at protein concentrations of 0.4 
(triangles), 0.2 (circles) and 0.1 (squares) mg 
ml-1. Spectra were acquired immediately after 
(solid lines) and 48h after (dashed lines) 
incubation under these conditions. 
 
 
Protein samples incubated in 5% TFE were analysed using tapping mode 
atomic force microscopy (TM-AFM). Since the sample was dried to facilitate its 
adhesion to the mica substrate, the measured aggregate sizes reported below 
are reduced with respect to fully hydrated conditions, the shrinking factor 
being 2.0-2.5 as previously evaluated (129). After 24 h of incubation, aggregates 
with a twisted, fibrillar appearance are observed (Fig. 3.4a). The fibrils have a 
height of 2.8±0.2 nm, while at their ends the height is reduced to 1.8±0.1 nm. 
The typical fibril length is 50-200 nm. After 48 h of incubation, longer fibrils 
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(typically from 300 nm to 1 µm) are found (Fig. 3.4b). Twisted fibrils with a 
height of 3.6±0.1 nm result from the intertwining of thinner filaments whose 
diameter exhibits a bimodal distribution with peaks around 1.2 and 2.3 nm and 
mean value 1.9±0.1 nm. Given the shrinking factor of 2.0-2.5, the 3.6 nm high 
fibrils and their constituent 1.9 nm high filaments have widths consistent of 
amyloid fibrils and protofilaments, respectively. Overall, the aggregates formed 
from AcPDro2 analysed here appear to have morphological, structural and 
tinctorial properties typical of amyloid-like structures. 
 
Figure 3.4 TM-AFM images (amplitude data; the insets show height data) of AcPDro2 
aggregates obtained in 5% TFE after 24h (a) and 48h (b). Image sizes are (a) 1.0x0.8 µm, inset 
380x320 nm; (b) 1.9x1.3 µm, inset 300x270 nm.The Z ranges for the height data reported in the 
insets are (a) 15 nm and (b) 10 nm.  
 
 
3.3 AcPDro2 is initially in its native-like state 
 
Next we investigated the conformational state adopted by AcPDro2 in 5% (v/v) 
TFE before the aggregates form. This was technically feasible due to the 
relatively slow kinetics of the process that allowed a biophysical investigation 
to be carried out before the aggregates accumulate significantly.  
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3.3.1 Early aggregation process monitored by Dynamic Light Scattering 
Dynamic light scattering (DLS) measurements were performed on protein 
samples with and without 5% (v/v) TFE added immediately before the 
measurements. Fig. 3.5 shows two representative size distributions by light 
scattering intensity obtained at a protein concentration of 0.5 mg ml-1, in 0% 
(solid line) and 5% TFE (dashed line). The peaks at 3.77±0.13 and 4.10±0.13 nm 
observed in 0 and 5% (v/v) TFE, respectively, are consistent with the 
hydrodynamic diameter of native and monomeric AcPDro2, as determined by 
the x-ray crystallographic structure (94) (errors reported in the manuscript 
indicate std. dev.). All pairs of measurements, carried out at different protein 
concentrations, show that the apparent hydrodynamic diameters measured in 
5% (v/v) TFE are within error to those measured in the absence of TFE (Fig. 3.5, 
inset). This result led us to the conclusion that a monomeric form of AcPDro2, 
with a compactness similar to that of the native protein, is the most represented 
in solution before the aggregation 
process starts. 
 
Figure 3.5 Size distibutions by light scattering 
intensity of AcPDro2 in 0% (solid line) and 5% 
(dashed line) TFE. The inset shows the 
apparent diameters measured at different 
protein oncentrations in 0% (filled circles) and 
5% (empty circles) TFE. 
 
 
The secondary structure content of AcPDro2 prior to aggregation was 
investigated using far-UV CD. The CD spectra of AcPDro2, recorded 
immediately after the addition of 1, 2, 3, 4 and 5% (v/v) TFE, are very similar to 
that obtained for the native protein in the absence of TFE. Fig. 3.6 shows that 
